Study of ammoxetine tablets in people with moderate kidney problems
Part of Kidney & urinary clinical trials.
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You weigh at least 45 kg (99 lbs) if female, or 50 kg (110 lbs) if male.
- You have moderate kidney problems (as determined by your doctor) or normal kidney function.
- You are willing to use effective birth control from 2 weeks before the study until 6 months after, and not donate sperm or eggs.
- You have no history of severe allergies, heart disease, or other major medical conditions that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
This study tests whether a new version of an antidepressant pill is absorbed the same way as the existing one, and whether food changes how it is absorbed. Participants take the pill and have blood tests to measure drug levels.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
This study is for healthy volunteers to see how a new experimental drug (JMKX003142) interacts with other drugs in the body. It helps find the right dose for future patients.
This study tests how the body handles an investigational drug called PKN605 in people with different levels of kidney function. It aims to see if the drug is safe and how it is processed when kidneys are impaired, which can help doctors decide the right dose for people with kidney disease.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.